The Hôpital de La Grave is a hospital situated in the Saint-Cyprien quartier of Toulouse in Southwest France on the left bank of the Garonne.

During the past decade, Hopital La Grave conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital La Grave" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Affiris AG" with 2 trials sponsored, "Biogen" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "ANRS, Emerging Infectious Diseases" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital La Grave" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "French Cardiology Society" with 1 trials as a collaborator, "IMEA Leon M'Ba Foundation" with 1 trials as a collaborator, "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator and "Janssen Alzheimer Immunotherapy (JAI) Research and Development, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Hopital La Grave" are "Alzheimer's Disease" (8 trials), "Alzheimer Disease" (2 trials), "Alzheimer´s Disease" (1 trials), "Cardiovascular Mortality" (1 trials) and "Cognitive Impairment" (1 trials). Many other conditions were trialed in "Hopital La Grave" in a lesser frequency.

Most popular intervention types in "Hopital La Grave" are "Drug" (9 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "ACC-001" (1 trials), "ACC-001 + QS-21" (1 trials), "ACC-001(10µg) + QS21" (1 trials) and "ACC-001(30µg) + QS21" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital La Grave" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Hopital La Grave". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Hopital La Grave, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital La Grave, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".